Access to biologicals in Crohn's disease in ten European countries

Marta Pentek, Peter L. Lakatos, Talitha Oorsprong, Laszlo Gulacsi*, Milena Pavlova, Wim Groot, Fanni Rencz, Valentin Brodszky, Petra Baji, Crohn's Dis Res Grp

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)6294-6305
Number of pages12
JournalWorld Journal of Gastroenterology
Volume23
Issue number34
DOIs
Publication statusPublished - 14 Sep 2017

Keywords

  • Crohn's disease
  • Biological therapy
  • Access
  • Inequality
  • Europe
  • INFLAMMATORY-BOWEL-DISEASE
  • RHEUMATOID-ARTHRITIS
  • ULCERATIVE-COLITIS
  • THERAPY
  • DRUGS
  • METAANALYSIS
  • BURDEN
  • LIFE

Cite this

Pentek, M., Lakatos, P. L., Oorsprong, T., Gulacsi, L., Pavlova, M., Groot, W., Rencz, F., Brodszky, V., Baji, P., & Crohn's Dis Res Grp (2017). Access to biologicals in Crohn's disease in ten European countries. World Journal of Gastroenterology, 23(34), 6294-6305. https://doi.org/10.3748/wjg.v23.i34.6294